Danyi Wen, MBA, MSc, MD
Founder, President & CEO
Shanghai LIDE Co. Ltd. (LIDE)
Dr. Wen’s research foundation was 12 years at Millennium Pharmaceutical, Biogen-Idec in Boston, MA. In 2007, attracted by the innovation coming from overseas, she returned to China as VP of Biology at Shanghai ChemPartner. She founded Shanghai LIDE Biotech in 2011 to drive research and development in personalized precision medicine.
She maintains strong alliances in the academic space and serves as adjourn professor of Beijing Xiehe Hospital and School of Pharmacy of Fudan University and an instructor at Shanghai Technology University.
She is a key opinion leader in the drug development space, serving as editor of “Progress in Pharmaceutical Sciences”, Director of PhiRDA, CRO Sub-Group and President of SDDA (Sino-Drug Discovery Association). She is also an Associate of Chinese anti-cancer Association (society of Liver, bile, Pancreatic); Vice Group Leader of CMBA Tissue Bank Society and PDX Group.